Group Purchasing Organizations
Group Purchasing Organizations (GPOs) negotiate bulk discounts on medical supplies, devices, and prescription drugs for hospitals and clinics. They were created to leverage collective buying power — but their fee structure, like PBMs, can reward higher prices instead of lower ones.
A Group Purchasing Organization is an entity that aggregates the purchasing volume of multiple healthcare providers to negotiate discounted prices with suppliers. Hospitals join GPOs to access pre-negotiated contracts on everything from surgical gloves to oncology drugs.
GPOs control an estimated $300B+ in annual hospital purchasing. For prescription drugs, GPOs negotiate directly with manufacturers for volume-based discounts — but they are paid by the suppliers, not the hospitals, which creates the same conflict of interest that plagues PBMs.
Who's at the table: the stakeholders
The GPO ecosystem connects six distinct parties. Understanding who they are — and where their financial incentives point — is essential to understanding why GPO purchasing works the way it does.
Hospitals & Health Systems
The buyersHospitals, health systems, and integrated delivery networks join GPOs as members to access pre-negotiated contracts. They pay little or nothing to join — the GPO is funded by supplier fees. A single hospital may belong to multiple GPOs simultaneously.
Manufacturers
The suppliersDrug manufacturers and medical device companies negotiate contracts with GPOs to gain access to the GPO’s member network. They offer volume-based discounts and pay admin fees (1–3%) to the GPO in exchange for preferred placement on contract portfolios.
Distributors
The logistics layerCardinal Health, McKesson, and AmerisourceBergen distribute the products under GPO-negotiated terms. Distributors often hold their own GPO contracts and may serve as the contracting intermediary between manufacturers and providers.
The GPO itself
The intermediaryThe GPO aggregates demand, negotiates contracts, and manages the contract portfolio. It earns revenue primarily from supplier-paid admin fees — not from the hospitals it serves. This revenue model is the source of the structural conflict of interest.
Physicians & Clinicians
The end usersDoctors and clinical staff often have limited visibility into the contracts governing the products they use. GPO contracts may steer purchasing toward specific suppliers, limiting clinician choice on everything from surgical implants to oncology drugs.
Patients
The ultimate payersPatients never interact with a GPO directly, but the prices negotiated in GPO contracts flow through to hospital charges, insurance reimbursements, and out-of-pocket costs. When GPO fee structures inflate prices, patients absorb the difference.
How organizations use GPO purchasing
GPO membership gives providers access to pre-negotiated contracts, but the terms, categories, and commitment levels vary widely. Here's what organizations can — and can't — do through GPO purchasing.
Multi-category contracts
A single GPO contract portfolio can cover pharmaceuticals, medical-surgical supplies, implants, lab equipment, food service, and even office supplies. Hospitals can buy across dozens of categories through one GPO membership.
Compliance & off-contract buying
GPO contracts are typically voluntary — hospitals are not required to buy exclusively through the GPO. But many contracts include compliance targets (e.g., 80% of volume) that unlock deeper discounts, pressuring hospitals to stay on-contract.
Custom & committed contracts
Large health systems can negotiate "committed" contracts with volume guarantees in exchange for steeper discounts. Smaller facilities use standard GPO contracts with no commitment. The largest systems may bypass GPOs entirely and self-contract.
Multi-GPO membership
Hospitals commonly belong to 2–4 GPOs at once, using different GPOs for different product categories. A hospital might use Vizient for medical-surgical supplies and Premier for pharmaceuticals, cherry-picking the best contract in each category.
How GPOs negotiate drug prices
The four-step model: aggregate volume, negotiate contracts, collect fees, and grant member access. The negotiation is real — but the fee structure undermines the savings.
Aggregation
GPOs pool purchasing volume from thousands of hospitals and clinics, creating massive buying power no single provider could match alone.
Contract negotiation
GPOs negotiate volume-based discounts with drug manufacturers and distributors. Manufacturers offer lower prices in exchange for guaranteed volume.
Admin fees
Manufacturers pay the GPO an "administrative fee" (1–3% of sales) for inclusion in the contract portfolio. This fee is the GPO’s primary revenue source.
Member access
Hospitals buy through the GPO contract at the negotiated price. The GPO’s fee is baked into the price the hospital pays — the hospital never sees a separate bill.
The dominant players
The top GPOs control the vast majority of hospital purchasing volume. Several are owned by or affiliated with major hospital systems.
Vizient
~$100B+
annual purchasing volume
Largest GPO; formed from VHA, Novation, and Provista
Premier Inc.
~$55B
annual purchasing volume
Publicly traded; owns Performancemanager analytics
HealthTrust
~$20B
annual purchasing volume
Owned by HCA Healthcare
Intalere
~$15B
annual purchasing volume
Owned by University of Rochester Medical Center
The conflict of interest
Admin fees = kickbacks
GPOs collect "administrative fees" from suppliers — typically 1–3% of purchase price. Like PBM rebates, these flow from the seller to the buyer’s intermediary, creating a structural incentive to favor higher-priced suppliers who pay bigger fees.
Safe harbor from anti-kickback law
GPOs enjoy a "safe harbor" exemption from federal anti-kickback statutes, allowing them to accept supplier payments that would otherwise be illegal. Critics argue this exemption has been stretched far beyond its original intent.
Higher prices, not lower
When GPOs earn fees as a percentage of price, they have little incentive to push prices down. Some studies suggest GPO-negotiated contracts can cost more than what providers could negotiate independently.
Market concentration
The top 6 GPOs control roughly 90% of hospital purchasing volume. This concentration limits competition among suppliers and gives GPOs enormous gatekeeping power over what products hospitals can buy.
Why this matters for patients
GPOs were created to help hospitals save money by pooling buying power. And for basic supplies like gloves and syringes, they often do. But for prescription drugs and high-cost medical devices, the fee structure creates a perverse incentive: the GPO earns more when prices are higher, because admin fees are a percentage of the purchase price.
The result is a system where the intermediary profits from higher prices, the supplier is rewarded for keeping them up, and the hospital — and ultimately the patient — may pay more than if the hospital had negotiated directly. The same structural problem that makes PBM rebates behave like kickbacks applies to GPO admin fees: the party negotiating the price is not the party paying it.
Disclaimer: For educational and informational purposes only. This dashboard aggregates publicly available data from IRS Form 990 filings and third-party sources; figures may be incomplete, estimated, or out of date. Nothing here constitutes legal, financial, tax, or medical advice, or an endorsement or judgment of any organization or individual. Always verify with official filings and qualified professionals before relying on any figure.